Description

• General description: When working on a pharmaceutical formulation, there are specific considerations to make and challenging hurdles to take before you can successfully launch your final drug product - formulation stability, release kinetics and bioavailability limitations just to name a few. With our application know-how and regulatory expertise, we support you in every step of development, scale-up, and production.As part of our Emprove® Program, our raw materials are offered with extensive documentation facilitating compliance of your pharma and biopharma product, full supply chain transparency and risk mitigation. Our SAFC® portfolio of high-quality products for biopharmaceutical and pharmaceutical formulation and production withstands strict quality control procedures and is produced according to applicable cGMP guidelines.
• Application: Meglumine Emprove® Essential is a robust pharmaceutical excipient that can provide stability, solubility enhancement and pH modification in solid and liquid formulations.
• Features and Benefits: Solubility and bioavailability enhancement of APIs Excellent counterion performance, a viable alternative to sodium API grade: manufactured under the cGMP ICH Q7 guideline for APIs Sole manufacturing location for API-grade meglumine in Europe Multi-compendial product, complying with all major pharmacopeias, including ChP Meglumine Emprove® API has also been successfully co-reviewed in China
• Legal Information: Emprove is a registered trademark of Merck KGaA, Darmstadt, Germany